Major Femoral Bleeding Complications After Percutaneous Coronary Intervention. Incidence, Predictors, and Impact on Long-Term Survival Among 17,901 Patients Treated at the Mayo Clinic From 1994 to 2005

Brendan J. Doyle, Henry H. Ting, Malcolm R. Bell, Ryan J. Lennon, Verghese Mathew, Mandeep Singh, David Holmes, Charanjit Rihal

Research output: Contribution to journalArticle

206 Citations (Scopus)

Abstract

Objectives: The purpose of this study was to evaluate secular trends and factors associated with major femoral bleeding after percutaneous coronary intervention (PCI) in routine clinical practice during the past decade and to assess the impact of these complications on outcomes including mortality. Background: Significant changes in patient demographic data, adjunctive pharmacotherapy, and access site management have occurred during the coronary stent era. Trends in major vascular complications after PCI during this time have not been well characterized. Methods: Consecutive patients who underwent transfemoral PCI from 1994 to 2005 at the Mayo Clinic (n = 17,901) were studied. Patients were divided into 3 groups: Group 1 (1994 to 1995, n = 2,441); Group 2 (1996 to 1999, n = 6,207); and Group 3 (2000 to 2005, n = 9,253). Results: The incidence of major femoral bleeding complications decreased (from 8.4% to 5.3% to 3.5%; p < 0.001). Reductions in sheath size, intensity and duration of anticoagulation with heparin, and procedure time were observed (p < 0.001), and multivariate analysis confirmed each as an independent predictor of complications (p < 0.001). Adverse outcomes of major femoral bleeding included prolonged hospital stay (mean 4.5 vs. 2.7 days; p < 0.0001) and increased requirement for blood transfusion (39% vs. 4.7%; p < 0.0001). Major femoral bleeding and blood transfusion were both associated with decreased long-term survival, driven by a significant increase in 30-day mortality (p < 0.001 for both). Conclusions: We noted a marked decline in the incidence of major femoral bleeding after PCI over the past decade. Mortality associated with these bleeding complications and with blood transfusion remains a significant issue.

Original languageEnglish (US)
Pages (from-to)202-209
Number of pages8
JournalJACC: Cardiovascular Interventions
Volume1
Issue number2
DOIs
StatePublished - Apr 2008

Fingerprint

Percutaneous Coronary Intervention
Thigh
Hemorrhage
Survival
Incidence
Blood Transfusion
Mortality
Stents
Blood Vessels
Heparin
Length of Stay
Multivariate Analysis
Demography
Drug Therapy

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Major Femoral Bleeding Complications After Percutaneous Coronary Intervention. Incidence, Predictors, and Impact on Long-Term Survival Among 17,901 Patients Treated at the Mayo Clinic From 1994 to 2005. / Doyle, Brendan J.; Ting, Henry H.; Bell, Malcolm R.; Lennon, Ryan J.; Mathew, Verghese; Singh, Mandeep; Holmes, David; Rihal, Charanjit.

In: JACC: Cardiovascular Interventions, Vol. 1, No. 2, 04.2008, p. 202-209.

Research output: Contribution to journalArticle

Doyle, Brendan J. ; Ting, Henry H. ; Bell, Malcolm R. ; Lennon, Ryan J. ; Mathew, Verghese ; Singh, Mandeep ; Holmes, David ; Rihal, Charanjit. / Major Femoral Bleeding Complications After Percutaneous Coronary Intervention. Incidence, Predictors, and Impact on Long-Term Survival Among 17,901 Patients Treated at the Mayo Clinic From 1994 to 2005. In: JACC: Cardiovascular Interventions. 2008 ; Vol. 1, No. 2. pp. 202-209.
@article{507c7d95fe07416f9dc7fee03b38bd2c,
title = "Major Femoral Bleeding Complications After Percutaneous Coronary Intervention. Incidence, Predictors, and Impact on Long-Term Survival Among 17,901 Patients Treated at the Mayo Clinic From 1994 to 2005",
abstract = "Objectives: The purpose of this study was to evaluate secular trends and factors associated with major femoral bleeding after percutaneous coronary intervention (PCI) in routine clinical practice during the past decade and to assess the impact of these complications on outcomes including mortality. Background: Significant changes in patient demographic data, adjunctive pharmacotherapy, and access site management have occurred during the coronary stent era. Trends in major vascular complications after PCI during this time have not been well characterized. Methods: Consecutive patients who underwent transfemoral PCI from 1994 to 2005 at the Mayo Clinic (n = 17,901) were studied. Patients were divided into 3 groups: Group 1 (1994 to 1995, n = 2,441); Group 2 (1996 to 1999, n = 6,207); and Group 3 (2000 to 2005, n = 9,253). Results: The incidence of major femoral bleeding complications decreased (from 8.4{\%} to 5.3{\%} to 3.5{\%}; p < 0.001). Reductions in sheath size, intensity and duration of anticoagulation with heparin, and procedure time were observed (p < 0.001), and multivariate analysis confirmed each as an independent predictor of complications (p < 0.001). Adverse outcomes of major femoral bleeding included prolonged hospital stay (mean 4.5 vs. 2.7 days; p < 0.0001) and increased requirement for blood transfusion (39{\%} vs. 4.7{\%}; p < 0.0001). Major femoral bleeding and blood transfusion were both associated with decreased long-term survival, driven by a significant increase in 30-day mortality (p < 0.001 for both). Conclusions: We noted a marked decline in the incidence of major femoral bleeding after PCI over the past decade. Mortality associated with these bleeding complications and with blood transfusion remains a significant issue.",
author = "Doyle, {Brendan J.} and Ting, {Henry H.} and Bell, {Malcolm R.} and Lennon, {Ryan J.} and Verghese Mathew and Mandeep Singh and David Holmes and Charanjit Rihal",
year = "2008",
month = "4",
doi = "10.1016/j.jcin.2007.12.006",
language = "English (US)",
volume = "1",
pages = "202--209",
journal = "JACC: Cardiovascular Interventions",
issn = "1936-8798",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Major Femoral Bleeding Complications After Percutaneous Coronary Intervention. Incidence, Predictors, and Impact on Long-Term Survival Among 17,901 Patients Treated at the Mayo Clinic From 1994 to 2005

AU - Doyle, Brendan J.

AU - Ting, Henry H.

AU - Bell, Malcolm R.

AU - Lennon, Ryan J.

AU - Mathew, Verghese

AU - Singh, Mandeep

AU - Holmes, David

AU - Rihal, Charanjit

PY - 2008/4

Y1 - 2008/4

N2 - Objectives: The purpose of this study was to evaluate secular trends and factors associated with major femoral bleeding after percutaneous coronary intervention (PCI) in routine clinical practice during the past decade and to assess the impact of these complications on outcomes including mortality. Background: Significant changes in patient demographic data, adjunctive pharmacotherapy, and access site management have occurred during the coronary stent era. Trends in major vascular complications after PCI during this time have not been well characterized. Methods: Consecutive patients who underwent transfemoral PCI from 1994 to 2005 at the Mayo Clinic (n = 17,901) were studied. Patients were divided into 3 groups: Group 1 (1994 to 1995, n = 2,441); Group 2 (1996 to 1999, n = 6,207); and Group 3 (2000 to 2005, n = 9,253). Results: The incidence of major femoral bleeding complications decreased (from 8.4% to 5.3% to 3.5%; p < 0.001). Reductions in sheath size, intensity and duration of anticoagulation with heparin, and procedure time were observed (p < 0.001), and multivariate analysis confirmed each as an independent predictor of complications (p < 0.001). Adverse outcomes of major femoral bleeding included prolonged hospital stay (mean 4.5 vs. 2.7 days; p < 0.0001) and increased requirement for blood transfusion (39% vs. 4.7%; p < 0.0001). Major femoral bleeding and blood transfusion were both associated with decreased long-term survival, driven by a significant increase in 30-day mortality (p < 0.001 for both). Conclusions: We noted a marked decline in the incidence of major femoral bleeding after PCI over the past decade. Mortality associated with these bleeding complications and with blood transfusion remains a significant issue.

AB - Objectives: The purpose of this study was to evaluate secular trends and factors associated with major femoral bleeding after percutaneous coronary intervention (PCI) in routine clinical practice during the past decade and to assess the impact of these complications on outcomes including mortality. Background: Significant changes in patient demographic data, adjunctive pharmacotherapy, and access site management have occurred during the coronary stent era. Trends in major vascular complications after PCI during this time have not been well characterized. Methods: Consecutive patients who underwent transfemoral PCI from 1994 to 2005 at the Mayo Clinic (n = 17,901) were studied. Patients were divided into 3 groups: Group 1 (1994 to 1995, n = 2,441); Group 2 (1996 to 1999, n = 6,207); and Group 3 (2000 to 2005, n = 9,253). Results: The incidence of major femoral bleeding complications decreased (from 8.4% to 5.3% to 3.5%; p < 0.001). Reductions in sheath size, intensity and duration of anticoagulation with heparin, and procedure time were observed (p < 0.001), and multivariate analysis confirmed each as an independent predictor of complications (p < 0.001). Adverse outcomes of major femoral bleeding included prolonged hospital stay (mean 4.5 vs. 2.7 days; p < 0.0001) and increased requirement for blood transfusion (39% vs. 4.7%; p < 0.0001). Major femoral bleeding and blood transfusion were both associated with decreased long-term survival, driven by a significant increase in 30-day mortality (p < 0.001 for both). Conclusions: We noted a marked decline in the incidence of major femoral bleeding after PCI over the past decade. Mortality associated with these bleeding complications and with blood transfusion remains a significant issue.

UR - http://www.scopus.com/inward/record.url?scp=41949118346&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=41949118346&partnerID=8YFLogxK

U2 - 10.1016/j.jcin.2007.12.006

DO - 10.1016/j.jcin.2007.12.006

M3 - Article

C2 - 19463301

AN - SCOPUS:41949118346

VL - 1

SP - 202

EP - 209

JO - JACC: Cardiovascular Interventions

JF - JACC: Cardiovascular Interventions

SN - 1936-8798

IS - 2

ER -